Evidence map›Paper›PMID 10086337›Full record

ArticleOncogene1999

Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion.

B Valentinis, A Morrione, F Peruzzi, M Prisco, K Reiss, R Baserga

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. IPF pathogenesis is dependent upon TGFβ induction of IGF-1.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Anoikis resistance: an essential prerequisite for tumor metastasis.International journal of cell biology · 2012
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Regulation of breast cancer metastasis by IGF signaling.Journal of mammary gland biology and neoplasia · 2008
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

B ValentinisKimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
A Morrione
F Peruzzi
M Prisco
K Reiss
R Baserga

Funding

BIOLOGY OF THE PROLIFERATING CELL NUCLEAR ANTIGENR01CA053484 · NCI · THOMAS JEFFERSON UNIVERSITY · PI BASERGA, RENATO LUIGI · 1991 to 2000
$179k
BIOLOGY OF THE P53 PROTEINR01GM033694 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI BASERGA, RENATO LUIGI · 1985 to 1999
–
NCI NIH HHS CA 53484NIGMS NIH HHS GM33694
6 · The paper itself

Abstract

The type 1 insulin-like growth factor receptor (IGF-IR) is known to protect cells from a variety of apoptotic injuries. In several instances, the anti-apoptotic effect of the wild type IGF-IR is more evident under conditions of anchorage-independence than in cells in monolayer cultures. We have investigated IGF-IR signaling in cells in anoikis, a form of apoptosis that occurs when cells are denied attachment to the extra-cellular matrix. IGF-I protects mouse embryo fibroblasts (MEF) from anoikis caused by withdrawal of growth factors. Survival is dependent on the concentration of IGF-I and a sufficient number of functional IGF-I receptors. In this model, IGF-I protection correlates best with ras activation and cell-to-cell aggregation, while PI3-kinase, Akt and MAP kinases seem to play a lesser, alternative role.

Indexed as

ApoptosisMitogen-Activated Protein KinasesSignal Transduction3T3 CellsAndrostadienesAnimalsCalcium-Calmodulin-Dependent Protein KinasesCell SurvivalChromonesEnzyme InhibitorsExtracellular MatrixFibroblastsHumansInsulin-Like Growth Factor IMiceMice, Inbred BALB C2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneAndrostadienesCalcium-Calmodulin-Dependent Protein KinasesChromonesEnzyme InhibitorsInsulin-Like Growth Factor IMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesMorpholinesOncogene Protein v-aktPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPolyhydroxyethyl Methacrylateras ProteinsReceptor, IGF Type 1Retroviridae Proteins, OncogenicWortmannin

Identifiers

PMID10086337

What Socratic holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.